Immunological considerations and challenges for regenerative cellular therapies. (2021)
Attributed to:
Immunogenicity test platform - in vitro and in vivo
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s42003-021-02237-4
PubMed Identifier: 34172826
Publication URI: http://europepmc.org/abstract/MED/34172826
Type: Journal Article/Review
Volume: 4
Parent Publication: Communications biology
Issue: 1
ISSN: 2399-3642